06/27/2024 | Press release | Distributed by Public on 06/27/2024 15:00
Item 5.07 Submission of Matters to a Vote of Security Holders.
The Annual Meeting of Stockholders (the "Annual Meeting") of Cullinan Therapeutics, Inc. (the "Company") was held on June 26, 2024. The stockholders present voted on the two proposals presented at the Annual Meeting as follows.
Proposal One - Election of Directors
The Company's stockholders elected two Class I directors to the Company's Board of Directors for three-year terms or until her or his successor has been duly elected and qualified, or until her or his earlier death, resignation or removal, by the following votes:
Nominee |
Votes For |
Votes Withheld |
Broker Non-Votes |
Anne-Marie Martin, Ph.D. |
25,054,060 |
11,471,277 |
4,156,894 |
David Meek |
36,409,849 |
115,488 |
4,156,894 |
Proposal Two - Ratification of Appointment of Independent Registered Accounting Firm
The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2024 by the following votes:
Votes For |
Votes Against |
Abstentions |
Broker Non-Votes |
40,163,993 |
516,975 |
1,263 |
0 |